<html>
<head>PUBMED IDs for FRA7G</head>
<body bgcolor='#C5F0F2'><h1>FRA7G</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9400999/'>Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.</a> December 24  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9485032/'>A molecular cytogenetic analysis of 7q31 in prostate cancer.</a> March 4  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9491327/'>Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer.</a> March 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9620548/'>FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites.</a> June 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9801158/'>Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers.</a> November 4  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9892108/'>Frequent deletions within FRA7G at 7q31.2 in invasive epithelial ovarian cancer.</a> January 19  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10950921/'>Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.</a> August 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10951309/'>Innervation of the human costovertebral joint: implications for clinical back pain syndromes.</a> August 22  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12086891/'>A role for common fragile site induction in amplification of human oncogenes.</a> June 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12620387/'>Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer.</a> March 7  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12759258/'>Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.</a> May 22  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15168591/'>Alterations of common chromosome fragile sites in hematopoietic malignancies.</a> June 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15305200/'>Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.</a> August 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16186806/'>Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma.</a> September 28  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16954539/'>Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.</a> September 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17039484/'>Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1--relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints.</a> October 14  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18078840/'>Human chromosome fragility.</a> December 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/22957844/'>Testin is a tumor suppressor and prognostic marker in breast cancer.</a> February 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22957840/'>Low expression of tissue inhibitor of metalloproteinase-2 may be associated with high-risk myelodysplastic syndrome.</a> November 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/26339916/'>[Biological role and prognostic significance of genetic alterations in human malignant melanomas].</a> December 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28000866/'>Testin is a tumor suppressor in non-small cell lung cancer.</a> December 22  2016<br></body></html>
